CG Oncology, Inc. Common stockCGONNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank25
3Y CAGR-28.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-28.3%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$32.49M-87.4%
2024$257.07M+3009.9%
2023$8.27M-90.6%
2022$88.14M+64.4%
2021$53.61M-